Doximity, Inc. Class A Common Stock (NY:DOCS)

33.00 -0.39 (-1.17%)

Delayed Quote Updated: 3:12 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 11, 2022

Gainers Cosmos Holdings (NASDAQ:COSM) shares increased by 27.9% to $0.15 during Friday's pre-market session. The market value of their outstanding shares is at $12.3 million.

Via Benzinga

Why AirSculpt Technologies Shares Are Trading Lower By 20%; Here Are 31 Stocks Moving Premarket ↗

November 11, 2022

Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.7% to $3.93 in pre-market trading after the company reported a $5 million share repurchase program.

Via Benzinga

Doximity, Matterport And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 11, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

8 Analysts Have This to Say About Doximity ↗

October 24, 2022

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Via Benzinga

What 7 Analyst Ratings Have To Say About Doximity ↗

October 13, 2022

Analysts have provided the following ratings for Doximity (NYSE:DOCS) within the last quarter:

Via Benzinga

7 Analysts Have This to Say About Doximity ↗

October 13, 2022

Doximity (NYSE:DOCS) has observed the following analyst ratings within the last quarter:

Via Benzinga

Doximity, Beazer Homes And 3 Stocks To Watch Heading Into Friday ↗

November 11, 2022

With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Why Doximity Stock Is Soaring After Hours ↗

November 10, 2022

Doximity Inc (NYSE: DOCS) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected

Via Benzinga

Doximity Announces Fiscal 2023 Second Quarter Financial Results

November 10, 2022

From Doximity

Via Business Wire

Why Shares of Doximity Dropped 12.4% in October ↗

November 07, 2022

Investors are expecting lower Doximity revenue from advertising.

Via The Motley Fool

2 Beaten-Down Growth Stocks You Can Confidently Buy Right Now ↗

November 06, 2022

These fast-growing businesses have what they need to weather an economic downturn.

Via The Motley Fool

Analyst Ratings for Doximity ↗

September 07, 2022

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 ↗

October 31, 2022

Upgrades

Via Benzinga

3 Beaten-Down Growth Stocks That Could Soar 44.1% to 52.1%, According to Wall Street ↗

October 31, 2022

The analysts who follow these fast-growing businesses think their stock prices could shoot much higher.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022 ↗

October 24, 2022

Upgrades

Via Benzinga

Doximity to Release Fiscal 2023 Second Quarter Results on November 10, 2022

October 20, 2022

From Doximity

Via Business Wire

Which of These Bear Market Growth Stocks Is More Likely to Bounce Back? ↗

October 19, 2022

Both look like bargains, but only one is.

Via The Motley Fool

3 Growth Stocks That Could Soar 62.6% to 66.3%, According to Wall Street ↗

October 18, 2022

Find out why analysts have such high hopes for these top growth stocks.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗

October 13, 2022

Upgrades

Via Benzinga

Why Now Is the Time to Buy Telehealth Stocks ↗

October 13, 2022

Stocks in this beaten-down industry possess exciting growth opportunities in the long run.

Via The Motley Fool

Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday ↗

October 13, 2022

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.

Via Benzinga

Cameco, Kinnate Biopharma And Other Big Losers From Wednesday ↗

October 13, 2022

U.S. stocks closed slightly lower on Wednesday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday's Mid-Day Session ↗

October 12, 2022

Gainers Code Chain New Continent Limited (NYSE: CCNC) shares jumped 74% to $0.2868 after declining around 14% on Tuesday.

Via Benzinga

2 High-Conviction Growth Stocks Down 51.4% and 70.9% to Buy Now and Hold Forever ↗

October 10, 2022

The road ahead of these fast-growing businesses is in better shape than their stock prices would suggest.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022 ↗

September 16, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 26, 2022

Via Benzinga

Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday ↗

August 10, 2022

U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗

August 09, 2022

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.